How one of only a few multidisciplinary treatment programs for SMA in Virginia cares for children throughout the region.
Author: Megan Davis (Page 7)
One of only 15 healthcare centers in the country with the expertise to treat FMD effectively, UVA Health Heart & Vascular is contributing to research efforts that could lead to new therapies for this complex and serious disease.
UVA Health is among the few high-volume cardiac care centers in the country with the requisite skills and dedicated expertise to tackle chronic total occlusion. Find out how we achieve high success rates and life-changing outcomes.
A UVA Health researcher and colleagues have found that a new drug combination may lengthen survival in patients with advanced non-squamous NSCLC.
Discover the new worldwide leader in translational FUS immuno-oncology research.
A team of UVA Health researchers has found evidence that screening for STAT3 mutations will help to better classify and diagnose patients with LGL leukemia.
Serving as a quaternary referral center, we give patients access to innovative procedures and devices only available at select centers.
Hypertrophic cardiomyopathy has historically been less well-understood than other cardiac conditions, but research at UVA Health is opening the door to tailored interventions.
Through a significant investment over 8 years, we became Virginia's first National Cancer Institute-designated comprehensive cancer center.
UVA Health’s facial reanimation program is one of a handful of programs in the U.S. offering the full spectrum of treatments aimed at giving patients with facial paralysis the ability to create more natural facial expressions.